An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients

Clinical Transplantation

Volumn 18, Issue 4, 2004, Pages 450-455

  Câmara, Niels Olsen S ^a   Dias, Mônica Felizardo L ^a   Pacheco Silva, Alvaro ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute rejection; Immunosuppression; Living donors; Renal transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE DISEASE; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAFT SURVIVAL; HAPLOTYPE; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; RISK FACTOR; STATISTICAL ANALYSIS; URINARY TRACT INFECTION;

AZATHIOPRINE; CYCLOSPORINE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIVING DONORS; POSTOPERATIVE PERIOD; TIME FACTORS;

EID: 4043144255     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00190.x     Document Type: Article

References (21)

1. Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med 1994: 331: 365.
2. Matas AJ, Payne WD, Sutherland DE et al. 2,500 living donor kidney transplants: a single-center experience. Ann Surg 2001: 234: 149.
3. Tarantino A. Why should we implement living donation in renal transplantation? Clin Nephrol 2000: 53: 55.
4. Abecassis M, Adams M, Adams P et al. Consensus statement on the live organ donor. JAMA 2000: 13: 2919.
5. Shafizadeh S, McEvoy JR, Murray C et al. Laparoscopic donor nephrectomy: impact on an established renal transplant program. Am Surg 2000: 66: 1132.
6. Cecka JM, Terasaki PI. TheUNOS scientific renal transplant registry. In: Cecka JM, Terasaki PI eds. Clinical Transplants 1995. Los Angeles: UCLA Tissue Typing Laboratory, 1996:1.
7. Arrazola L, Sozen H, Humar A, Papalois V, Uknis M, Matas AJ. Both immunologic and nonimmunologic factors are risks for long-term graft survival - a multivariate analysis. Transplant Proc 2000: 32: 1831.
8. Humar A, Ramcharan T, Kandaswamy R, Gillingham K, Payne WD, Matas AJ. Risk factors for slow graft function after kidney transplants: a multivariate analysis. Clin Transplant 2002: 16: 425.
9. Paraskevas S, Kandaswamy R, Humar A et al. Predicting long-term kidney graft survival: can new trials be performed? Transplantation 2003: 75: 1256.
10. Pollard SG, Lear PA, Ready AR et al. Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. Transplantation 1999: 68: 1325.
11. Suthanthiran M, Strom TB. Mechanisms and management of acute renal allograft rejection. Surg Clin North Am 1998: 78: 77.
12. Magee CC, Denton MD, Milford EL. Immunosuppressive agents in organ transplantation. Hosp Med 1999: 60: 364.
13. http://www.centerspan.org. Page accessed on 06/21/1999.
14. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713.
15. Belitsky P. Neoral use in the renal transplant recipient. Transplant Proc 2000: 32: 10S.
16. First MR. Clinical application of immunosupressive agents in renal transplantation. Surg Clin North Am 1998: 78: 61.
17. Humar A, Payne WD, Sutherland DER, Matas AJ. Clinical determinants of multiple acute rejection episodes in kidney transplant recipients. Transplantation 2000: 69: 2357.
18. Papalois VE, Moss A, Gillingham KJ et al. Pre-emptive transplants for patients with renal failure. Transplantation 2000: 70: 625.
19. Barama A, Oza U, Panek R et al. Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants. Clin Transplant 2000: 14: 212.
20. Foss A, Leivestad T, Brekke IB et al. Unrelated living donors in 141 kidney transplantations: a one-center study. Transplantation 1998: 66: 49.
21. Johnson RWG. The clinical impact of nephrotoxicity in renal transplantation. Transplantation 2000: 69: S14.